Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-156990
Filing Date
2019-05-24
Accepted
2019-05-24 16:06:55
Documents
3
Effectiveness Date
2019-05-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A d752364ddefa14a.htm DEFA14A 18617
2 GRAPHIC g752364g45k51.jpg GRAPHIC 4909
3 GRAPHIC g752364g99u76.jpg GRAPHIC 9069
  Complete submission text file 0001193125-19-156990.txt   39433
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19311 | Film No.: 19854505
SIC: 2836 Biological Products, (No Diagnostic Substances)